Evaluating a new pacing method for heart failure patients
Official title: Acute Response to Left Bundle Branch Area Pacing With SyncAV
Run by Abbott Medical Devices · NCT06436053 · Data updated 2026-11-12
This study is testing a new pacing method for heart failure patients to see if it can improve their heart function.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Abbott Medical Devices Industry-sponsored |
| Locations | 1 site (San Donato Milanese, MI) |
| Status | Recruiting |
| Started | May 15, 2024 |
| Main results expected | December 15, 2026 |
| Study ends | July 15, 2027 |
| Registry record updated | July 9, 2026 |
| Trial ID | NCT06436053 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older with left bundle branch block or intraventricular conduction delay who require dual-chamber pacing or cardiac resynchronization therapy.
✕Probably not a fit
Patients with high resting heart rates, significant AV block, or recent cardiac events may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical investigation is a prospective, single-arm, post-market study that aims to assess the effectiveness of the SyncAV dynamic atrioventricular delay feature in conjunction with left bundle branch area pacing (LBBAP) for patients with heart failure. The study will involve patients who are scheduled to receive an Abbott pacing system and have specific conduction abnormalities. By monitoring the outcomes of these patients, the study seeks to provide insights into the benefits of this pacing approach in improving heart function.
Why it matters
Potential benefit: If successful, this approach could enhance heart function and quality of life for patients with heart failure.
How similar studies have gone: While this approach is innovative, similar studies have shown promise in improving outcomes for heart failure patients with pacing interventions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patient is 18 years of age and willing to comply with the study requirements 2. Patients with approved indication for dual-chamber pacing or cardiac resynchronization therapy and scheduled to be implanted with an Abbott pacing system 3. Patient has documented left bundle branch block (LBBB) or intraventricular conduction delay (IVCD) 4. Patient has an intrinsic QRS duration ≥ 130 ms 5. Patient has intact AV conduction with PR interval ≤ 250 ms Exclusion Criteria: 1. Patient has a resting ventricular rate \> 100 bpm 2. Patient has AV Block (2nd or 3rd degree) 3. Patient has documented persistent atrial tachycardia or atrial fibrillation 4. Patient has had a recent myocardial infarction, ablation, electrolyte imbalance, or any condition within the last 90 days that would contraindicate for pacing device programming changes in the opinion of the investigator 5. Patient is currently participating in another clinical investigation 6. Patient is pregnant or nursing 7. Patient has other medical, anatomic, comorbid, social, or psychological conditions that, in the investigator's opinion, could limit the subject's ability to participate in the clinical investigation or to comply with follow-up requirements, or impact the scientific soundness of the clinical investigation results 8. Patient does not have legal authority 9. Patient is unable to read or write
Where it's running
-
I.R.C.C.S. Policlinico San Donato
San Donato Milanese, Mi, Italy Recruiting
Study contacts
- Study coordinator: Nima Badie, PhD
- Email: nima.badie@abbott.com
- Phone: 408-702-8604
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
NT-proBNP–guided heart failure screening for people 65+ in rural China
This study tests whether using NT-proBNP blood tests to guide heart failure screening in adults 65 and older in rural China can find unrecognized heart problems more effectively than symptom-based screening.
-
Voice-based detection of heart failure deterioration using Noah Labs Vox
This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.